Integra LifeSciences Corporation, headquartered in the United States, is a prominent player in the health and social work services industry, specifically focusing on advanced medical technologies. Founded in 1989, the company has achieved significant milestones, including the development of innovative solutions in neurosurgery, orthopaedics, and regenerative medicine.
Integra's core offerings include a diverse range of products such as surgical instruments, wound care solutions, and tissue regeneration technologies. What sets Integra apart is its commitment to enhancing patient outcomes through cutting-edge research and development. With a strong market position, the company has garnered recognition for its contributions to improving surgical procedures and patient care, solidifying its reputation as a leader in the healthcare sector.
+5 vs industry average
Integra lifesciences’s score of 28 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Integra lifesciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Health Services has typical carbon intensity
Industry performance
The Health Services industry has reduced its overall emissions by 23% since 2018
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Integra lifesciences's reported carbon emissions
Integra LifeSciences, a US-based company operating in the Health and social work services (85) industry, reported a total of approximately 119.7 million kg CO2e for fiscal year 2024. This includes Scope 1 emissions of about 14.6 million kg CO2e, Scope 2 emissions of approximately 11.9 million kg CO2e, and Scope 3 emissions totalling approximately 96.2 million kg CO2e.
In the preceding year, 2023, Integra LifeSciences' total emissions were approximately 170.2 million kg CO2e. This comprised Scope 1 emissions of around 8.3 million kg CO2e, Scope 2 emissions of about 15.3 million kg CO2e, and Scope 3 emissions of approximately 156.7 million kg CO2e.
For fiscal year 2022, the company's total emissions reached approximately 188.2 million kg CO2e, with Scope 1 emissions at about 13.2 million kg CO2e, Scope 2 emissions at approximately 16.2 million kg CO2e, and Scope 3 emissions of around 159 million kg CO2e.
In 2021, Integra LifeSciences reported total emissions of about 191.5 million kg CO2e, consisting of Scope 1 emissions of approximately 13.9 million kg CO2e and Scope 2 emissions of around 18.6 million kg CO2e. Scope 3 emissions data was not disclosed for this year.
Integra LifeSciences has not publicly disclosed specific reduction targets or initiatives in the provided information.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Integra lifesciences’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Integra lifesciences yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Integra lifesciences
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project